California’s Proposed Ban on Artificial Stone Reflects Growing Concern Over Silicosis
June 22, 2026
Pleural Effusion Fluid Accumulates Around the Lung Symptoms
June 26, 2026
Image Credit: Netherlands Cancer Institute
How AI is Helping to Transform Mesothelioma Care
A groundbreaking development from the Netherlands Cancer Institute is helping to transform how physicians evaluate and treat pleural mesothelioma. Researchers created the AI model ARTIMES which helps measure tumors more accurately than current clinical standards – and even outperforms physicians in assessing treatment response.
Traditionally, doctors use RECIST criteria to measure tumor sizes based on diameter. This criterion works for many cancers, but pleural mesothelioma is a unique challenge due to the cancer’s irregular growth along lung walls, making it more difficult to measure. These measurement challenges, in turn, can make it difficult to determine whether treatments are effective.
The AI model ARTIMES addresses this problem by analyzing the tumors’ entire volume instead of relying on single measurements. ARTIMES was trained on over 11,000 CT scans from over 2,000 patients around the world and can track subtle changes over time, providing a more comprehensive picture of pleural mesothelioma tumor progression or response to treatment.
With more precise measurements, physicians can identify ineffective treatments earlier, allowing patients to switch to different treatments sooner. ARTIMES has the potential to improve care outcomes and to reduce unnecessary side effects and healthcare costs. The model’s findings are always reviewed by physicians to ensure that human expertise remains central in decision making.
Beyond individual patient care, ARTIMES could accelerate the development of new cancer treatments. By improving the accuracy of tumor response measurements, clinical trials can become more reliable and efficient. While currently used at the Netherlands Cancer Institute, researchers are working to expand access worldwide. As AI continues to evolve, innovations like ARTIMES signal a new era in oncology where technology enhances confidence and hope in cancer treatment.
If you or a loved one has been diagnosed with mesothelioma, you may have legal options. Brayton Purcell LLP has decades of experience helping victims of asbestos exposure pursue compensation. Contact our team today for a free consultation and learn how we can help you move forward.